Tailored Medical Devices, Inc. (TMDI) develops products for the treatment of blocked arteries in the legs, a disease commonly known as peripheral artery disease. The team is looking to capitalize on advances made in the peripheral artery disease field by developing its patented drug-coated balloon (TMDI-DCB) technology to final product and approval stages. The firm's long-term mission is to research, develop, and license drug-delivery medical devices in the cardiovascular field as well as other broad ranges of medicine.
